Not FDA-approved
Brain & sleep
Selank
Evidence
Regional approval, limited trials
Class
Synthetic analog of tuftsin
KEY TAKEAWAY
Selank is a synthetic peptide related to a natural immune peptide called tuftsin. It has been studied in Russia for anxiety and is not approved by the FDA.
Written by the Veylo editorial team · Updated
November 2026
What it is
A synthetic tuftsin analog studied for anxiety
Studied for
Anxiety and stress-related symptoms
Key fact
Small studies in Russia reported anxiety reduction; independent confirmation is lacking
Route
Nasal spray
Evidence strength
Regional approval, limited trials
Selank is a heptapeptide created by adding a short sequence to tuftsin so it lasts longer in the body.
Preclinical work points to effects on GABA signaling and serotonin and dopamine turnover. Human mechanism data are sparse.
Selank is registered as a medicine in Russia. It has no FDA approval.
Studied for generalized anxiety and mood symptoms. Evidence outside small regional trials is limited.
Mild effects such as nasal irritation and drowsiness have been described. Long-term safety is unknown.
Primary literature for this entry is being compiled.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.